drugset / Trial / NCT02665689

Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab

NCT02665689

RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of the prospective randomized study is to investigate whether a intensified diabetic control program leads to better final visual acuity and less frequent diabetic ocular complications in patients with diabetic retinopathy when compared with a normal diabetic treatment.

Timeline

Start
2016-01-18
Primary completion
2018-09-07
Completion
2018-09-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ranibizumab Monoclonal antibody 0.5 mg Intravitreal